Fibroids

5,112 views 50 slides Dec 26, 2019
Slide 1
Slide 1 of 50
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50

About This Presentation

Clinical evaluation and management of fibroids


Slide Content

Fibroids – Clinical presentation and evaluation

Uterine leiomyomas (also referred to as fibroids or myomas) are the most common pelvic tumor in women They are benign monoclonal tumors arising from the smooth muscle cells of the myometrium.

FIGO Classification

Submucosal myomas (FIGO type 0, 1, 2) – These leiomyomas derive from myometrial cells just below the endometrium (lining of the uterine cavity). These neoplasms protrude into the uterine cavity. The extent of this protrusion is described by the FIGO/European Society of Hysteroscopy classification system and is clinically relevant for predicting outcomes of hysteroscopic myomectomy •Type 0 – Completely within the endometrial cavity •Type 1 – Extend less than 50 percent into the myometrium •Type 2 – Extend 50 percent or more within the myometrium

Intramural myomas (FIGO type 3, 4, 5) – These leiomyomas are located within the uterine wall. They may enlarge sufficiently to distort the uterine cavity or serosal surface. Some fibroids may be transmural and extend from the serosal to the mucosal surface . Subserosal myomas (FIGO type 6, 7) – These leiomyomas originate from the myometrium at the serosal surface of the uterus. They may have a broad or pedunculated base and may be intraligamentary ( ie , extending between the folds of the broad ligament ). Cervical myomas (FIGO type 8) – These leiomyomas are located in the cervix rather than the uterine corpus.

Broad ligament fibroid

Cervical fibroid

Multiple fibroids

CASE 1 Mrs XYZ 45yr old P2L2 (FTND), with complaints of Heaviness in abdomen Irregular heavy menses Dysmenorrhea , since 2 – 3 months On Examination : P/A – soft, non tender P/S - cervix , vagina healthy P/V – uterus bulky firm mobile, AV, soft to cystic mass 4x5 cm in right and posterior fornix separate from uterus. Left fornix free and non tender. P/R – bogginess felt anteriorly, rectal mucosa and parametrium free. Tumour Marker - WNL

Investigations: USG Pelvis: solid , hypoechoic , well-circumscribed right adnexal mass of size 3.6x4.6 cm

What is your diagnosis?

BROAD LIGAMENT FIBROID

How will You differentiate between a True and False Broad Ligament Fibroid ? What will be relation of the Ureter to this fibroid?

True Broad Ligament False Broad Ligament Originates from the muscle fibres normally found in the mesometrium (in the round ligament, ovario -uterine ligament, and the connective tissue around the uterine and ovarian vessels) Arises from the lateral wall of the uterine corpus or of the cervix, and bulges outward between the layers of the broad ligament . Ureter is medial to mass Ureter is lateral to mass No groove felt between mass and uterus Groove felt between mass and uterus

In this case the right ureter was safeguarded by dissection and enucleation could be carried out rather easily.

RISK FACTORS Race  — The incidence rates of fibroids are typically found to be two- to threefold greater in black women than in white women  Parity  — Parity (having one or more pregnancies extending beyond 20 weeks of gestation) decreases the chance of fibroid formation  Early menarche  — Early menarche (<10 years old) is associated with an increased risk of developing fibroids . Hormonal contraception  — Use of standard or lower dose oral contraceptives (≤35 mcg ethinyl estradiol/day) do not appear to cause fibroids to grow

Other endocrine factors  — Prenatal exposure to diethylstilbestrol is associated with an increased risk of fibroids Smoking  – Early studies showed that smoking decreased the risk of having fibroids, possibly through the inhibition of aromatase Others - Diet, Alcohol, Obesity

pathogenesis Transformation of normal myocytes into abnormal myocytes, in most instances through somatic mutations Growth of abnormal myocytes into clinically apparent tumors

Histology Smooth muscle bundles arranged in whorl patterns Abndant amount of Collagen 1 & 3 present

Genetic predisposition Uterine leiomyomas are a common phenotype with many underlying genotypes. Both somatic and inherited mutations account for the majority of uterine fibroids, with the most common mutations occurring in the  MED12 ,  HMGA1  and  HMGA2 ,  FH , collagen type IV, alpha-5 ( COL4A5 ) and collagen type IV alpha-6 ( COL4A6 ) genes

Steroid hormone factors that influence leiomyoma development include upregulation of aromatase , estrogen, and progesterone receptors as well as a potential role of gonadotropins . Stem cells appear to also play a key role in fibroid pathogenesis

cLinical features The majority of myomas are small and asymptomatic , but many women with fibroids have significant problems that interfere with some aspect of their lives and warrant therapy. These symptoms are related to the number, size , and location of the tumors. Myomas can occur as single or multiple tumors and range in size from microscopic to tens of centimeters. The size of the myomatous uterus is described in menstrual weeks as with the gravid uterus.

Symptoms are classified into three categories : ●Heavy or prolonged menstrual bleeding ●Bulk-related symptoms, such as pelvic pressure and pain ●Reproductive dysfunction ( ie , infertility or obstetric complications)

Heavy or prolonged menstrual bleeding  Heavy or prolonged menses is the typical bleeding pattern with leiomyomas and the most common fibroid symptom Submucosal myomas that protrude into the uterine cavity ( eg , types 0 and 1)are most frequently related to significant heavy menstrual bleeding

Bulk-related symptoms Pelvic pressure or pain  — In general, pelvic discomfort is common in women with fibroids but less common than AUB. If discomfort is present, it is likely to be chronic, intermittent, dull pressure or pain Bowel symptoms – Fibroids that place pressure on the rectum can result in constipation

Urinary symptoms – A heterogeneous group of urinary symptoms including frequency, difficulty emptying the bladder, or, rarely, complete urinary obstruction may all occur in up to 60 percent of women with fibroids . Bladder symptoms sometimes arise when an anterior fibroid presses directly on the bladder or a posterior fibroid pushes the entire uterus forward

Infertility or obstetric complications  Leiomyomas that distort the uterine cavity (submucosal or intramural with an intracavitary component) result in difficulty conceiving a pregnancy and an increased risk of miscarriage In addition, leiomyomas have been associated with adverse pregnancy outcomes ( eg , placental abruption, fetal growth restriction, malpresentation, and preterm labor and birth)

others Painful menses  — Painful menses is reported by many women with fibroids Painful intercourse  — It is controversial whether women with fibroids are more likely to experience painful intercourse than women without fibroids Fibroid degeneration or torsion

diagnosis History Taking – It is important to assess the severity of heavy or prolonged menstrual bleeding. A menstrual history is taken and the volume and duration of bleeding elicited For women with pelvic pain or pressure , the location, severity, and characteristics of the pain should be assessed

Patients should be asked about other potential pain or bulk-related symptoms, including dyspareunia , urinary retention , or constipation. The patient should be asked about infertility, recurrent miscarriage, or obstetric complications that may be related to fibroids.

Physical Examination A thorough pelvic examination is performed. On bimanual pelvic examination , the size, contour, and mobility should be noted. An enlarged, mobile uterus with an irregular contour is consistent with a leiomyomatous uterus.  Size, shape, surface, consistency, mobility, fluctuation

Pelvic ultrasound Pelvic ultrasound is the first-line study used to evaluate for uterine fibroids. Transvaginal ultrasound has high sensitivity (95 to 100 percent) for detecting myomas in uteri less than 10 gestational weeks' size. Precise localization of fibroids is limited in larger uteri or when there are many tumors.

Fibroids are seen on ultrasound usually as hypoechoic , well-circumscribed round masses, frequently with shadowing

C alcification in a fibroid generally implies that it has degenerated. These calcifications can be seen on plain film as "popcorn" calcifications in the pelvis.  On ultrasound, the calcifications may appear as clumps or rim-like calcifications within a mass

Evaluate the uterine cavity Saline infusion sonography  — Saline infusion sonography ( sonohysterography ) is an imaging study in which pelvic ultrasound is performed while saline is infused into the uterine cavity. Use of this technique allows identification of submucosal lesions (some of which may not be seen on routine ultrasonography) and intramural myomas that protrude into the cavity and characterizes the extent of protrusion into the endometrial cavity

Hysteroscopy  — Diagnostic hysteroscopy is useful for visualizing the endometrial cavity. Similar to saline infusion sonography, this allows evaluation for submucosal or protruding myometrial fibroids and can characterize the extent of protrusion. This can be performed in the office or operating room

Magnetic resonance imaging  — Magnetic resonance imaging (MRI) is the most effective modality for visualizing the size and location of all uterine myomas and can distinguish among leiomyomas, adenomyosis , and adenomyomas.

MRI Mapping Prior to myomectomy , it is very important to detect all the fibroids in the uterus however small and if not removed will lead to higher chances of recurrence. Ultrasound cannot detect fibroid less than 2 cm i.e seedling fibroids MRI is superior imaging technique for mapping all the fibroids because it can detect small seedling fibroids also

DIFFERENTIAL DIAGNOSIS  Adenomyosis Full Bladder Ovarian Cyst Edometrial Hyperplasia Endometrial Polyp Paraovarian lesions Pelvic Tumors Pregnancy Hematometra Fecolith

Management Medical Management Non Surgical Alternatives Surgical Management

Medical Management LNG IUCD’s Tranexemic Acid NSAID’s GnRH Agonist GnRH Antagonist Ulipristal Non Surgical Alternative Uterine Artery Embolisation Magnetic Resonance Guided Focused Ultrasound

Surgical management Laparoscopic Myomectomy Laparoscopic Hysterectomy Hysteroscopic Myomectomy

2 Lap myomeCtomy + 1 HysteroscopIc myomectomy Video

Summary Uterine leiomyomas are the most common pelvic tumor in women. Leiomyomas are benign monoclonal tumors arising from the smooth muscle cells of the myometrium Symptoms attributable to uterine myomas can generally be classified into three distinct categories: abnormal uterine bleeding (AUB), pelvic pressure and pain, and reproductive dysfunction Transvaginal ultrasound is the most widely used imaging modality for evaluating fibroids due to its availability and cost-effectiveness.  Laparoscopic rather than abdominal myomectomy for women with leiomyomas for whom laparoscopic removal is technically feasible (by size, number, and location) and who have access to a surgeon with advanced laparoscopic skills